Hospira's Inflectra™ (infliximab) the first biosimilar monoclonal antibody to be approved in Europe

LEAMINGTON SPA, England, Sept. 10, 2013 /PRNewswire/ -- Hospira (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced the European Commission (EC) approval of Inflectra™ (infliximab), Europe's first biosimilar monoclonal antibody... Reported by PR Newswire 3 hours ago.